seed
Stage
1
Investors
About
Vascversa develops advanced cell and gene therapies that regenerate retinal micro-vasculature to prevent and treat vision loss caused by ischemic retinal diseases such as diabetic retinopathy and age-related macular degeneration.
Explore Vascversa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.